Cellular & Metabolic Research

Retatrutide

10 mg

RESEARCH USE ONLY

An investigational triple-receptor agonist studied for interactions with GLP-1, GIP, and glucagon receptors.

Overview

Retatrutide is an investigational compound studied in research settings for interactions with GLP-1, GIP, and glucagon receptors. It is not approved by the FDA for human use.

Composition

Labeled strength: 10 mg. Confirm exact product form, lot information, storage requirements, and available documentation before ordering.

Documentation

Batch and Certificate of Analysis records may be available only where completed and verified. Contact support with the product name and lot identifier.

Form, packaging & storage

These specifications are provided only when manufacturer-validated. Please request current product information before ordering.

For legitimate laboratory and scientific research only. Not for human or veterinary use, consumption, injection, diagnosis, treatment, or disease prevention.